Galecto completes 1-for-25 reverse stock split; post-split shares at 1,248,266

Damora Therapeutics, Inc.

Reverse stock split effective August 29, 2024; every 25 shares converted to 1 share.
Computershare confirms total outstanding shares post-split: 1,248,266.
Fractional shares resulting from the reverse split were rounded up to the nearest whole share.

item 8.01

Damora Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-105533

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.